Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Plos One|December 3, 2010
Nearest template prediction: a single-sample-based flexible class prediction with confidence assessmentYujin Hoshida
Gastroenterology & Hepatology|May 26, 2021
Current Status of the Use of Statins and Aspirin in the Chemoprevention of Hepatocellular CarcinomaYujin Hoshida
Journal of Hepatology|September 15, 2009
Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrenceYujin Hoshida
Journal of Hepatology|July 10, 2009
Tumor-derived molecular information and outcome in hepatocellular carcinomaYujin Hoshida
Clinical Liver Disease|July 28, 2015
Molecular Epidemiology of Hepatocellular CarcinomaYujin Hoshida
Clinical and Molecular Hepatology|July 10, 2015
Hepatitis C virus-induced hepatocellular carcinomaNicolas Goossens, Yujin Hoshida
Clinical Liver Disease|May 2, 2019
Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futurasNicolas Goossens, Yujin Hoshida
Seminars in Liver Disease|March 27, 2019
Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with CirrhosisNaoto Fujiwara, Yujin Hoshida
Hepatology (Baltimore, Md.)|January 29, 2025
Mitochondrial genome diversity drives heterogeneity in HCCTatsuhiro Shibata, Yujin Hoshida
Clinical and Molecular Hepatology|October 11, 2024
Reply to correspondence on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial"Hiroaki Kanzaki, Yujin Hoshida
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Plos One|December 3, 2010
Nearest template prediction: a single-sample-based flexible class prediction with confidence assessmentYujin Hoshida
Gastroenterology & Hepatology|May 26, 2021
Current Status of the Use of Statins and Aspirin in the Chemoprevention of Hepatocellular CarcinomaYujin Hoshida
Journal of Hepatology|September 15, 2009
Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrenceYujin Hoshida
Journal of Hepatology|July 10, 2009
Tumor-derived molecular information and outcome in hepatocellular carcinomaYujin Hoshida
Clinical Liver Disease|July 28, 2015
Molecular Epidemiology of Hepatocellular CarcinomaYujin Hoshida
Clinical and Molecular Hepatology|July 10, 2015
Hepatitis C virus-induced hepatocellular carcinomaNicolas Goossens, Yujin Hoshida
Clinical Liver Disease|May 2, 2019
Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futurasNicolas Goossens, Yujin Hoshida
Seminars in Liver Disease|March 27, 2019
Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with CirrhosisNaoto Fujiwara, Yujin Hoshida
Hepatology (Baltimore, Md.)|January 29, 2025
Mitochondrial genome diversity drives heterogeneity in HCCTatsuhiro Shibata, Yujin Hoshida
Clinical and Molecular Hepatology|October 11, 2024
Reply to correspondence on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial"Hiroaki Kanzaki, Yujin Hoshida
Pageof 27